Visit COVID-19 resources

[Skip to Content]

The incidence of unexplained visual loss following removal of silicone oil – (Eye 29, 1477 (November 2015))

Nov 12
2015

The incidence of unexplained visual loss following removal of silicone oil Eye 29, 1477 (November 2015). doi:10.1038/eye.2015.135 Authors: R Moya, A Chandra, P J Banerjee, D Tsouris, N Ahmad & D G Charteris

  • 12 November 2015

The accuracy of the Edinburgh visual loss diagnostic algorithm – (Eye 29, 1483 (November 2015))

Nov 12
2015

The accuracy of the Edinburgh visual loss diagnostic algorithm Eye 29, 1483 (November 2015). doi:10.1038/eye.2015.146 Authors: C Goudie, A Khan, C Lowe & M Wright

  • 12 November 2015

Is day-1 postoperative review necessary after pars plana vitrectomy? – (Eye 29, 1489 (November 2015))

Nov 12
2015

Is day-1 postoperative review necessary after pars plana vitrectomy? Eye 29, 1489 (November 2015). doi:10.1038/eye.2015.134 Authors: P Alexander, L Michaels & R Newsom

  • 12 November 2015

Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study – (Eye 29, 1495 (November 2015))

Nov 12
2015

Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study Eye 29, 1495 (November 2015). doi:10.1038/eye.2015.163 Authors: K Mercieca, B Shevade & N Anand

  • 12 November 2015

Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS – (Eye 29, 1504 (November 2015))

Nov 12
2015

Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS Eye 29, 1504 (November 2015). doi:10.1038/eye.2015.151 Authors: H A Salmon, D Chalk, K Stein & N A Frost

  • 12 November 2015